Mannitol
๐ก Mannitol is an osmotic diuretic mainly used in emergencies such as raised intracranial or intraocular pressure.
It creates an osmotic gradient, pulling water out of tissues (e.g. brain, eye) into the intravascular space, where it can then be excreted via the kidneys.
- Osmotic diuretic โ does not cross intact cell membranes.
- Used in neurosurgical and ophthalmic emergencies.
โ๏ธ Mode of Action
- Increases plasma osmolality โ draws fluid out of brain/eye tissues.
- Filtered by the kidney but not reabsorbed โ osmotic diuresis.
- Reduces intracranial pressure (ICP) and intraocular pressure (IOP).
๐ Indications & Dosing (verify with BNF/datasheet)
- ๐ง Cerebral oedema / Raised ICP: Mannitol 20% solution, 1 g/kg IV infusion over 30โ60 minutes.
- โป๏ธ Dose can be repeated 1โ2 times after 4โ8 hours if needed.
- ๐๏ธ Raised intraocular pressure (acute glaucoma): similar dosing regimen.
๐ Interactions
โ ๏ธ Cautions
- For Mannitol 20%, use an in-line filter (15-micron filters commonly used) โ prevents crystallisation particles entering patient.
- Monitor renal function, electrolytes, and fluid balance closely.
โ Contraindications
- Severe left ventricular failure (LVF) or pulmonary oedema.
- Severe dehydration.
- Active intracranial bleeding (unless during craniotomy).
๐ฅ Side Effects
- Polyuria / diuresis, dehydration, electrolyte disturbances (โNaโบ, โKโบ).
- Headache, dizziness, blurred vision.
- Hypotension, tachycardia.
- GI upset: nausea, vomiting, diarrhoea, dry mouth, thirst.
- Allergic reactions: rash, urticaria, chills.
- Local: pain, irritation, or swelling at injection site.
๐ References